Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495

Cardiovasc Res. 2003 Oct 1;59(4):844-53. doi: 10.1016/s0008-6363(03)00505-4.

Abstract

Objective: The Ca2+ antagonist amlodipine increases the generation of nitric oxide (NO) from native and cultured endothelial cells. The aim of this investigation was to determine whether or not the activation of the endothelial NO synthase (eNOS) by this Ca2+ antagonist is related to alterations in eNOS phosphorylation.

Methods and results: In isolated, pre-contracted, endothelium-intact porcine coronary arteries, amlodipine elicited an NO-mediated relaxation and a leftward shift in the concentration-relaxation curve to bradykinin. Moreover, the Ca2+ antagonist increased the generation of NO from native endothelial cells, as detected by electron spin resonance spectroscopy and stimulated an 8-fold increase in cyclic GMP levels in cultured endothelial cells. In unstimulated endothelial cells, eNOS was not phosphorylated on Ser1177 but was phosphorylated on Thr495. Amlodipine elicited the phosphorylation of Ser1177 and attenuated Thr495 phosphorylation, with a time course similar to that of eNOS activation. The amlodipine-induced relaxation of porcine coronary arteries was attenuated by the B2 kinin receptor antagonist, icatibant, but this antagonist did not affect amlodipine-induced changes in eNOS phosphorylation in cultured endothelial cells. Moreover, amlodipine elicited the NO-mediated relaxation of rat aortic rings which do not express the B2 receptor. Amlodipine time-dependently attenuated the phosphorylation of protein kinase C (PKC) in endothelial cells, with a time course similar to the changes in eNOS phosphorylation, and prevented the phorbol-12-myristate-13-acetate-induced activation of PKC. The PKC inhibitor, Ro 31-8220, also elicited the phosphorylation of Ser1177 and the dephosphorylation of Thr495 in cultured cells and induced a leftward shift in the concentration-relaxation curve to bradykinin in rings of porcine coronary artery.

Conclusion: The Ca2+ antagonist, amlodipine, enhances endothelial NO generation by inducing changes in the phosphorylation of eNOS. Although the activation of eNOS was related to the activation of the B2 kinin receptor in the porcine coronary artery, a B2 receptor-independent mechanism involving the inhibition of PKC appears to account for the effects observed in the rat aorta as well as in cultured endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amlodipine / pharmacology*
  • Animals
  • Aorta
  • Bradykinin / analogs & derivatives*
  • Bradykinin / pharmacology
  • Bradykinin B2 Receptor Antagonists
  • Calcium Channel Blockers / pharmacology*
  • Cells, Cultured
  • Coronary Vessels
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Enzyme Activation
  • Humans
  • In Vitro Techniques
  • Indoles / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / metabolism*
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Inbred WKY
  • Serine / metabolism
  • Swine
  • Threonine / metabolism
  • Umbilical Veins
  • Vasodilation / drug effects

Substances

  • Bradykinin B2 Receptor Antagonists
  • Calcium Channel Blockers
  • Indoles
  • Amlodipine
  • Threonine
  • Nitric Oxide
  • Serine
  • icatibant
  • Nitric Oxide Synthase
  • Protein Kinase C
  • Bradykinin
  • Ro 31-8220